Clinical Trial Update: Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthritis Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of Buprenorphine Transdermal System for moderate to severe osteoarthritis pain; the study was terminated but result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• BUPRENORPHINE TRANSDERMAL SYSTEM (buprenorphine)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Osteoarthritis | Phase 3 | Status: TERMINATED | Results posted: 2010-09-15